Send Inquiry

Request To Call Back

HEPCINAT AND NATDAC TABLETS

Get a Price/Quote

HEPCINAT AND NATDAC TABLETS Specification

Origin of Medicine
India

Salt Composition
Sofosbuvir and Daclatasvir

Dosage Form
Solid oral tablet

Pacakaging (Quantity Per Box)
28 tablets per box

Indication
Treatment of HCV Genotypes 1, 3, 4, 5, 6

Drug Type
Allopathic

Ingredients
Sofosbuvir 400mg, Daclatasvir 60mg

Physical Form
Tablets

Function
Antiviral therapy for HCV

Recommended For
Chronic Hepatitis C Virus (HCV) infection

Dosage
As directed by physician, usually one tablet daily

Dosage Guidelines
Take orally at the same time every day, with or without food

Suitable For
Adults

Quantity
28 tablets per box (each) / 1 strip of 28 tablets

Storage Instructions
Store below 30C, protect from moisture and light

Strength
400mg (Sofosbuvir), 60mg (Daclatasvir)

Batch Number
As printed on packaging

Approval
USFDA Approved molecules

Container Type
HDPE bottle with child-resistant cap

Side Effects
Fatigue, headache, nausea

Brand Name
HEPCINAT (Sofosbuvir), NATDAC (Daclatasvir)

Shelf Life
24 months from manufacturing date

Route of Administration
Oral

Prescription/Non Prescription
Prescription Only

Colour
HEPCINAT Light blue, NATDAC Yellow

About HEPCINAT AND NATDAC TABLETS

Hepcinat And Natdac

Hepcinat + NatdacBrand Name: Hepcinat

Content: Sofosbuvir
Strength: 400mg
Form : Tablets
Packing: Pack of 28 tablets
Uses : Treating chronic hepatitis C virus (HCV) infection in certain patient
Manufactured by : Natco Pharma

Brand Name : Natdac

Content : Daclatasvir Dihydrochloride
Strengths : 60 mg
Form : Tablets
Packing : Pack of 28 Tablets
Uses : Treating chronic hepatitis C virus (HCV) infection in certain patient
Manufactured by : Natco Pharma

Note :- Hepcinat And Natdac Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Powerful Antiviral Therapy for Chronic Hepatitis C

HEPCINAT and NATDAC Tablets are expertly formulated for treating chronic Hepatitis C infection in adults. Featuring the potent active ingredients Sofosbuvir and Daclatasvir, they target multiple HCV genotypes for broad-spectrum efficacy. With convenient once-daily dosing and robust USFDA-approved molecules, these medications bring effective viral suppression and improved clinical outcomes in eligible patients.

Reliable Packaging and Prescription Safety

Both HEPCINAT and NATDAC tablets are supplied in HDPE bottles equipped with child-resistant caps, ensuring product integrity and safe storage. Each box contains a clear batch number and easy identification by colorlight blue for HEPCINAT, yellow for NATDAC. Available only via prescription, these medications guarantee regulated use under healthcare professional supervision.

Recommended Usage and Storage Guidelines

For optimal effectiveness, patients should take one tablet daily at the same time, with or without food, as prescribed. Each tablet should be stored in its original HDPE bottle below 30C, protected from light and moisture. Always consult your healthcare provider for guidance on use, and never exceed the recommended dosage.

FAQs of HEPCINAT AND NATDAC TABLETS:

Q: How should I take HEPCINAT and NATDAC tablets for Hepatitis C treatment?

A: You should take one tablet of eachHEPCINAT (Sofosbuvir 400mg) and NATDAC (Daclatasvir 60mg)by mouth once daily, with or without food, at the same time each day. Always follow the dosing instructions provided by your healthcare provider.

Q: What are the main benefits of using HEPCINAT and NATDAC tablets?

A: These tablets combine two powerful USFDA-approved antiviral agents, providing effective therapy against chronic Hepatitis C virus of genotypes 1, 3, 4, 5, and 6. Their once-daily regimen enhances convenience and supports better treatment adherence.

Q: What potential side effects should I be aware of while taking these medications?

A: Common side effects may include fatigue, headache, and nausea. Always inform your doctor if you experience any persistent or severe symptoms during treatment.

Q: Where should I store HEPCINAT and NATDAC tablets?

A: Store the tablets in their original HDPE bottle below 30C, protected from light, moisture, and out of reach of children. Do not use the medication past the printed expiration or 24 months from manufacturing date.

Q: Who is eligible to use HEPCINAT and NATDAC tablets?

A: These medications are recommended for adult patients diagnosed with chronic Hepatitis C infection. They are available strictly by prescription from qualified healthcare professionals.

Q: When should I contact my healthcare provider during therapy?

A: Contact your healthcare provider if you experience severe side effects, notice an allergic reaction, or have concerns regarding medication adherence. Do not discontinue use without medical advice.

Tell us about your requirement